Publications by authors named "Galina N Oleinikova"

Adiponectin is an adipose tissue hormone, participating in energy metabolism and involved in atherogenesis. Previously, it was found that adiponectin increases expression of the APOA1 (apolipoprotein A-1) gene in hepatocytes, but the mechanisms of this effect remained unexplored. Our aim was to investigate the role of adiponectin receptors AdipoR1/R2, AMP-activated protein kinase (AMPK), nuclear peroxisome proliferator-activated receptor alpha (PPARα) and liver X receptors (LXRs) in mediating the action of adiponectin on hepatic APOA1 expression in human hepatoma HepG2 cells.

View Article and Find Full Text PDF

ATP-binding cassette transporter A-I (ABCA1) is an ubiquitously expressed protein whose main function is the transmembrane transport of cholesterol and phospholipids. Synthesis of ABCA1 protein in liver is necessary for high-density lipoprotein (HDL) formation in mammals. Thus, the mechanism of ABCA1 gene expression regulation in hepatocytes are of critical importance.

View Article and Find Full Text PDF

C3 is an acute phase protein, and thus its plasma concentration increases quickly and drastically during the onset of inflammation. Insulin plays a complex role in inflammation. Elevated level of plasma C3 was shown to correlate with heightened fasting insulin levels and insulin resistance and appears to be a risk factor for the cardiovascular disease and atherosclerosis.

View Article and Find Full Text PDF

Reactive oxygen species damage various cell components including DNA, proteins, and lipids, and these impairments could be a reason for severe human diseases including atherosclerosis. Forkhead box O1 (FOXO1), an important metabolic transcription factor, upregulates antioxidant and proapoptotic genes during oxidative stress. Apolipoprotein A-I (ApoA-I) forms high density lipoprotein (HDL) particles that are responsible for cholesterol transfer from peripheral tissues to liver for removal in bile in vertebrates.

View Article and Find Full Text PDF

Apolipoprotein A-I (ApoA-I) is a key component of high density lipoproteins which possess anti-atherosclerotic and anti-inflammatory properties. Insulin is a crucial mediator of the glucose and lipid metabolism that has been implicated in atherosclerotic and inflammatory processes. Important mediators of insulin signaling such as Liver X Receptors (LXRs) and Forkhead Box A2 (FOXA2) are known to regulate apoA-I expression in liver.

View Article and Find Full Text PDF
Article Synopsis
  • ApoA-I is a key part of good cholesterol that helps prevent heart disease.
  • The study shows that a chemical called GW1929 can lower levels of ApoA-I by affecting how certain genes work in liver cells.
  • PPARγ, the gene affected by GW1929, plays a complicated role in controlling ApoA-I production and secretion in cells related to digestion and the liver.
View Article and Find Full Text PDF
Article Synopsis
  • Complement C3 helps protect our immune system and is controlled by special proteins called nuclear receptors.
  • One important nuclear receptor, HNF4α, boosts the production of the C3 gene by sticking to certain parts of its DNA in liver cells.
  • During inflammation, a protein called TNFα reduces HNF4α levels, but both TNFα and HNF4α work together to increase C3 gene activity in a unique way.
View Article and Find Full Text PDF